Ainos : Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19
Hamsters Receiving Ainos VELDONA Formulation Demonstrate Protection from COVID-19 Based on Prespecified Indicators of Clinical Outcomes AN DIEGO, CA / ACCESSWIRE / June 27,... | June 27, 2022
Source: marketscreener.com